ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000261490.1	ABT-263 (navitoclax)	Bladder urothelial carcinoma	0.007564942	Sensitive
ENSG00000261490.1	ABT-263 (navitoclax)	Pancreatic adenocarcinoma	0.005523026	Sensitive